Medeloop
-
Rene Caissie and Josh Walonoski
-
2021
-
San Francisco, CA
-
11-50 Employees
-
$15.5M, Series A
Overview
Medeloop is a Stanford founded healthcare technology company that has built an agentic AI platform for generating regulatory-grade medical research evidence from real-world healthcare data.
Key Technology Insights
The platform runs a team of specialised AI agents that emulate the full medical data research workflow, generating protocols, executing studies and producing Journal of the American Medical Association (JAMA) style manuscripts. Its federated design queries data in its native store rather than moving it, and it generates and executes code to analyse data and calculate verifiable statistics, which keeps hallucination risk low.
Industry Application
The most established applications of Medeloop is in health systems and academic research, where Stanford Medicine, Cedars Sinai and Hartford Healthcare currently use the platform for large-scale patient dataset analysis. In biopharma and contract research, it supports real-world evidence for regulatory submissions and clinical trial design, drawing on a Health Verity data partnership.
Strategic Perspective
Medeloop sits at an early growth stage, combining regulatory-grade rigour with the speed of agentic AI. Its advantage rests on a federated model that respects data governance, paired with regulatory credibility. The nearer-term opportunity lies in real-world evidence, with clinical decision support and personal device certification in the longer path.
